Mestag Therapeutics

Mestag Therapeutics is a fast-moving, stealth mode biotech, newly formed to explore emerging understanding of fibroblast subpopulations as targetable drivers of disease. Our goal is to bring transformative therapies to enriched patient populations with enduring unmet needs in inflammatory disease and oncology. Mestag Therapeutics’ founders are world leaders in fibroblast biology and severe diseases. We are actively assembling a driven, motivated team to explore new therapeutic opportunities. Backed by SV Health Investors, a leading life sciences & healthcare investor with over $3 billion in capital commitments, Mestag has raised capital from the Impact Medicine Fund, which invests in precision medicine therapeutics in areas of high unmet need. We are hiring! Reach out to learn more about opportunities to join our team.